CorrespondenceA variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome
Key Words
Cited by (0)
R.S.S. passed away during the preparation of this article.
N.R.-K. has nothing to disclose. A.R.K. has nothing to disclose. L.M.D. has nothing to disclose. K.G.E. has nothing to disclose. R.S.S. has nothing to disclose. R.S.L. has received study support from Solvay and a speaker honorarium from Merck-Serono.
Supported by National Institutes of Health (NIH) grant nos. K 12HD055882, “Career Development Program in Women's Health Research at Penn State” from the National Institute of Child Health and Human Development (NICHD), U54 HD34449, and General Clinical Research Center grant M01 RR10732 and construction grant C06 RR016499 to Pennsylvania State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD or the NIH.
This project is funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds (RSL- SAP 41-000-26343). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions.